Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide begins working from the first dose, but noticeable weight loss takes longer. Most people see appetite changes within the first one to two weeks, while meaningful weight reduction typically appears after four to eight weeks. Significant results build over months, not days, and the full effect of treatment unfolds across the entire titration journey. These are prescription-only medicines: a clinician decides whether semaglutide is appropriate for you and at what pace your dose progresses.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide is introduced at 0.25 mg weekly. That starting dose is not a therapeutic weight-loss dose; it exists to let your body adjust to the medicine before the dose climbs. Expecting dramatic weight loss here sets you up for disappointment, and it is probably the most common misconception our prescribers hear, the idea that nothing is happening if the scales haven't moved. Something is happening. Your gut is learning a new rhythm.
What many people do notice in these first weeks is a quieter appetite. Meals feel satisfying sooner. Snacking urges ease. Some people experience nausea, loose stools or burping as their digestive system adapts, these effects are typically mild and tend to settle within a week or two of each dose change. The NHS patient information for semaglutide lists these gastrointestinal effects as the most common, particularly at the start of treatment or after a dose increase.
Weight change in week one through four is usually modest. A kilogram or two is possible; nothing visible is also completely normal. If you are curious about how long semaglutide takes to start working, it helps to understand that the medicine is doing foundational work before visible results appear.
From week five, the dose typically increases to 0.5 mg, then 1.0 mg around week nine, following the prescriber's schedule. Each step up tends to deepen the appetite effect. This is where most people first notice the scales moving consistently.
For many, the 1.0 mg period is when weight loss becomes tangible, clothes fit differently, energy levels shift, habits around food start changing. You may find you are naturally eating less without counting anything. That is semaglutide working as intended: it slows gastric emptying, signals satiety to the brain, and reduces the reward-driven pull of food.
How quickly weight comes off at this stage varies considerably. Starting weight, diet, activity level, sleep quality and individual biology all play a role. Comparing your week-eight result to someone else's is rarely useful, and reading about how fast semaglutide works can help set more realistic expectations. If you want a fuller picture of how long weight loss takes on semaglutide, individual factors matter far more than averages suggest.
The STEP 1 trial) the pivotal study behind Wegovy's UK licence, ran for 68 weeks and reported an average weight reduction of around 15% in participants taking 2.4 mg semaglutide alongside a reduced-calorie diet and increased activity. That figure comes from the published STEP 1 paper in the New England Journal of Medicine. It is an average across thousands of participants, not a forecast for any individual.
The maintenance dose (2.4 mg, or now up to 7.2 mg for eligible patients) is where most of the clinical-trial weight loss occurs. Getting there takes sixteen to twenty weeks of titration. This means the timeline for how long semaglutide takes to work, in the sense implied by those headline figures, is somewhere between four and six months from the first injection.
Weight loss then continues, usually more slowly, through the maintenance period. People using Wegovy specifically may also find it useful to read about how long Wegovy takes to work, given that the titration schedule shapes when results become most noticeable. The Wegovy treatment overview covers the full licensed dose schedule and what the titration pathway looks like in practice. For people thinking about whether the medicine suits their situation, our weight-loss treatment page sets out the options available through nume.
A plateau is not a signal that semaglutide has stopped working. Weight loss naturally slows as body weight falls, because a lighter body burns fewer calories at rest. This is physiology, not failure. Plateaus mid-treatment are common and do not always mean the dose needs to change.
What genuinely affects the pace of results: consistency of weekly injections, diet quality (protein and fibre adequacy tend to matter most), hydration, sleep and how much lean muscle activity accompanies treatment. Stopping and restarting treatment resets some of the progress made, which is one reason continuity matters.
Semaglutide is a prescription-only medicine and the prescriber's oversight does not end at the first approval. At nume, a clinician reviews your progress before every repeat, meaning any concern about pace, side effects or how the dose is landing gets addressed by a real person. If questions come up between orders, our FAQs cover the most common ones, and the team is reachable seven days a week. For anyone ready to find out whether semaglutide is clinically suitable for them, speaking to our prescribers is the starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.